Natroba™ (spinosad) Topical Suspension, 0.9%
http://www.natroba.com
American Academy of Pediatrics treatment recommendations
http://aappolicy.aappublications.org/cgi/content/full/pediatrics;110/3/638
American Academy of Pediatrics parenting site: HealthyChildren.org
http://www.HealthyChildren.org
American Academy of Family Practitioners treatment recommendations
http://www.aafp.org/afp/20040115/349ph.html
National Association of School Nurses position statement
http://www.nasn.org/Default.aspx?tabid=237
Ask your doctor if Natroba Topical Suspension is right for you or your child.
INDICATION
Natroba Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients four (4) years of age and older.
IMPORTANT SAFETY INFORMATION
Natroba Topical Suspension contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic
exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants.
Most common adverse events were: application site redness (3%), redness and irritation of the eyes (2%) and application site irritation (1%).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.